{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:18:22Z","timestamp":1790705902334,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00535-015-1062-3","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T17:24:12Z","timestamp":1426699452000},"page":"1094-1102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis"],"prefix":"10.1007","volume":"50","author":[{"given":"Kouichi","family":"Asano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Umeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Maehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,19]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066\u201378.","journal-title":"N Engl J Med"},{"key":"1062_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","volume":"121","author":"WA Faubion Jr","year":"2001","unstructured":"Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255\u201360.","journal-title":"Gastroenterology"},{"key":"1062_CR3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/00365529609004876","volume":"31","author":"E Langholz","year":"1996","unstructured":"Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 1996;31:260\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"1062_CR4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2007.09.002","volume":"5","author":"IC Solberg","year":"2007","unstructured":"Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn\u2019s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1062_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ibd.20036","volume":"13","author":"T Jess","year":"2007","unstructured":"Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"1062_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/gast.2001.20912","volume":"120","author":"A Bitton","year":"2001","unstructured":"Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120:13\u201320.","journal-title":"Gastroenterology"},{"key":"1062_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ibd.20054","volume":"13","author":"M Ferrante","year":"2007","unstructured":"Ferrante M, Vermeire S, Katsanos KH, et al. Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis. 2007;13:123\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"1062_CR8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/gut.2010.211755","volume":"59","author":"D Turner","year":"2010","unstructured":"Turner D, Leach ST, Mack D, et al. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response. Gut. 2010;59:1207\u201312.","journal-title":"Gut"},{"key":"1062_CR9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","volume":"43","author":"CA Anderson","year":"2011","unstructured":"Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43:246\u201352.","journal-title":"Nat Genet"},{"key":"1062_CR10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00535-013-0866-2","volume":"49","author":"Y Arimura","year":"2014","unstructured":"Arimura Y, Isshiki H, Onodera K, et al. Characteristics of Japanese inflammatory bowel disease susceptibility loci. J Gastroenterol. 2014;49:1217\u201330.","journal-title":"J Gastroenterol"},{"key":"1062_CR11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u201324.","journal-title":"Nature"},{"key":"1062_CR12","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3748\/wjg.v18.i29.3806","volume":"18","author":"L Beaugerie","year":"2012","unstructured":"Beaugerie L, Sokol H. Clinical, serological and genetic predictors of inflammatory bowel disease course. World J Gastroenterol. 2012;18:3806\u201313.","journal-title":"World J Gastroenterol"},{"key":"1062_CR13","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/ibd.21293","volume":"16","author":"T Haritunians","year":"2010","unstructured":"Haritunians T, Taylor KD, Targan SR, et al. Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis. 2010;16:1830\u201340.","journal-title":"Inflamm Bowel Dis"},{"key":"1062_CR14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0016-5085(75)80101-6","volume":"68","author":"H Schachter","year":"1975","unstructured":"Schachter H, Kirsner JB. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology. 1975;68:591\u2013600.","journal-title":"Gastroenterology"},{"key":"1062_CR15","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1572-0241.1998.00607.x","volume":"93","author":"M Seo","year":"1998","unstructured":"Seo M, Okada M, Maeda K, Oh K. Correlation between endoscopic severity and the clinical activity index in ulcerative colitis. Am J Gastroenterol. 1998;93:2124\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1062_CR16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/ng.482","volume":"41","author":"K Asano","year":"2009","unstructured":"Asano K, Matsushita T, Umeno J, et al. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet. 2009;41:1325\u20139.","journal-title":"Nat Genet"},{"key":"1062_CR17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ng1885","volume":"38","author":"PI Bakker de","year":"2006","unstructured":"de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet. 2006;38:1166\u201372.","journal-title":"Nat Genet"},{"key":"1062_CR18","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978\u201389.","journal-title":"Am J Hum Genet"},{"key":"1062_CR19","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1002\/sim.5815","volume":"32","author":"B Zhou","year":"2013","unstructured":"Zhou B, Fine J, Laird G. Goodness-of-fit test for proportional subdistribution hazards model. Stat Med. 2013;32:3804\u201311.","journal-title":"Stat Med"},{"key":"1062_CR20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1399-0039.2003.00129.x","volume":"62","author":"T Ahmad","year":"2003","unstructured":"Ahmad T, Armuzzi A, Neville M, et al. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens. 2003;62:527\u201335.","journal-title":"Tissue Antigens"},{"key":"1062_CR21","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ibd.20431","volume":"14","author":"M Lappalainen","year":"2008","unstructured":"Lappalainen M, Halme L, Turunen U, et al. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflamm Bowel Dis. 2008;14:1118\u201324.","journal-title":"Inflamm Bowel Dis"},{"key":"1062_CR22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10350-004-0747-0","volume":"48","author":"V Annese","year":"2005","unstructured":"Annese V, Piepoli A, Latiano A, et al. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis Colon Rectum. 2005;48:57\u201364 (discussion 64-55).","journal-title":"Dis Colon Rectum"},{"key":"1062_CR23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.gene.6364123","volume":"5","author":"U Potocnik","year":"2004","unstructured":"Potocnik U, Ferkolj I, Glavac D, Dean M. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun. 2004;5:530\u20139.","journal-title":"Genes Immun"},{"key":"1062_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ibd.20046","volume":"13","author":"F Daniel","year":"2007","unstructured":"Daniel F, Loriot MA, Seksik P, et al. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. Inflamm Bowel Dis. 2007;13:19\u201323.","journal-title":"Inflamm Bowel Dis"},{"key":"1062_CR25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/ibd.21845","volume":"18","author":"SC Ng","year":"2012","unstructured":"Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis. 2012;18:1164\u201376.","journal-title":"Inflamm Bowel Dis"},{"key":"1062_CR26","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489\u201399.","journal-title":"Gastroenterology"},{"key":"1062_CR27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11894-014-0416-y","volume":"16","author":"T Billiet","year":"2014","unstructured":"Billiet T, Ferrante M, Van Assche G. The use of prognostic factors in inflammatory bowel diseases. Curr Gastroenterol Rep. 2014;16:416.","journal-title":"Curr Gastroenterol Rep"},{"key":"1062_CR28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/gut.2007.146357","volume":"57","author":"M Henriksen","year":"2008","unstructured":"Henriksen M, Jahnsen J, Lygren I, et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut. 2008;57:1518\u201323.","journal-title":"Gut"},{"key":"1062_CR29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/ajg.2012.190","volume":"107","author":"G Rosenfeld","year":"2012","unstructured":"Rosenfeld G, Bressler B. The truth about cigarette smoking and the risk of inflammatory bowel disease. Am J Gastroenterol. 2012;107:1407\u20138.","journal-title":"Am J Gastroenterol"},{"key":"1062_CR30","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s10620-008-0639-6","volume":"54","author":"MM Maher","year":"2009","unstructured":"Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci. 2009;54:2456\u201362.","journal-title":"Dig Dis Sci"},{"key":"1062_CR31","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1572-0241.2007.01265.x","volume":"102","author":"O Hoie","year":"2007","unstructured":"Hoie O, Wolters F, Riis L, et al. Ulcerative colitis: patient characteristics may predict 10-year disease recurrence in a European-wide population-based cohort. Am J Gastroenterol. 2007;102:1692\u2013701.","journal-title":"Am J Gastroenterol"},{"key":"1062_CR32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.crohns.2012.09.003","volume":"6","author":"A Dignass","year":"2012","unstructured":"Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965\u201390.","journal-title":"J Crohns Colitis"},{"key":"1062_CR33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11894-012-0248-6","volume":"14","author":"AV Weizman","year":"2012","unstructured":"Weizman AV, Silverberg MS. Have genomic discoveries in inflammatory bowel disease translated into clinical progress? Curr Gastroenterol Rep. 2012;14:139\u201345.","journal-title":"Curr Gastroenterol Rep"},{"key":"1062_CR34","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00262-013-1452-4","volume":"62","author":"B Charbonneau","year":"2013","unstructured":"Charbonneau B, Wang AH, Maurer MJ, et al. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis. Cancer Immunol Immunother. 2013;62:1475\u201384.","journal-title":"Cancer Immunol Immunother"},{"key":"1062_CR35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nri856","volume":"2","author":"T Takai","year":"2002","unstructured":"Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol. 2002;2:580\u201392.","journal-title":"Nat Rev Immunol"},{"key":"1062_CR36","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1136\/ard.2008.096982","volume":"68","author":"JD Canete","year":"2009","unstructured":"Canete JD, Suarez B, Hernandez MV, et al. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis. 2009;68:1547\u201352.","journal-title":"Ann Rheum Dis"},{"key":"1062_CR37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/FPC.0000000000000042","volume":"24","author":"A Montes","year":"2014","unstructured":"Montes A, Perez-Pampin E, Narvaez J, et al. Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis. Pharmacogenet Genomics. 2014;24:238\u201345.","journal-title":"Pharmacogenet Genomics"},{"key":"1062_CR38","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1371\/journal.pgen.0030058","volume":"3","author":"C Libioulle","year":"2007","unstructured":"Libioulle C, Louis E, Hansoul S, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 2007;3:e58.","journal-title":"PLoS Genet"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-015-1062-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-015-1062-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-015-1062-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T10:57:42Z","timestamp":1651575462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-015-1062-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,19]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1007\/s00535-015-1062-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,19]]}}}